Showing results (141-150 of 157) with videos related to
Sort By:
Pageof 16
Elife|March 10, 2018
Proteolytic processing of palmitoylated Hedgehog peptides specifies the 3-4 intervein region of the <i>Drosophila</i> wingSabine Schürmann, Georg Steffes, Dominique Manikowski, et al.Biological Psychiatry|January 30, 2019
Specific Substantial Dysconnectivity in Schizophrenia: A Transdiagnostic Multimodal Meta-analysis of Resting-State Functional and Structural Magnetic Resonance Imaging StudiesFelix Brandl, Mihai Avram, Benedikt Weise, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell CarcinomaIvelina Spassova, Selma Ugurel, Patrick Terheyden, et al.Nature Communications|March 9, 2021
Specific inhibition of the Survivin-CRM1 interaction by peptide-modified molecular tweezersAnnika Meiners, Sandra Bäcker, Inesa Hadrović, et al.Bioinformatics (Oxford, England)|September 8, 2005
Computational methods for the design of effective therapies against drug resistant HIV strainsNiko Beerenwinkel, Tobias Sing, Thomas Lengauer, et al.Gastroenterology|March 8, 2011
CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteinsMarianne Ruhl, Torben Knuschke, Kevin Schewior, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 18, 2015
Virus-Induced Type I Interferon Deteriorates Control of Systemic Pseudomonas Aeruginosa InfectionKatja Merches, Vishal Khairnar, Torben Knuschke, et al.Frontiers in Immunology|February 15, 2021
Integrin Alpha E (CD103) Limits Virus-Induced IFN-I Production in Conventional Dendritic CellsVikas Duhan, Vishal Khairnar, Simo Kitanovski, et al.Ebiomedicine|July 29, 2022
Dissecting drivers of immune activation in chronic HIV-1 infectionHendrik Streeck, Alvino Maestri, Daniel Habermann, et al.Journal for Immunotherapy of Cancer|January 25, 2022
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinomaIvelina Spassova, Selma Ugurel, Linda Kubat, et al.Pageof 16